Adenomyosis Affects Fertility and ART Procedures as Well as Outcomes: An Invited Opinion

Angela G. Sison‐Aguilar
In: Fertility & Reproduction · 2024 · vol. 06(04) , pp. 154–155 · doi:10.1142/s2661318224020031 · W4406597756
article OA: diamond CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This opinion piece argues for distinct definitions and standardized, noninvasive diagnostic criteria for adenomyosis, suggesting that analyzing sonographic markers individually may clarify its reproductive impact.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The effect of adenomyosis on reproduction can only be determined if there are clear definitions of this disease entity. Adenomyosis should be distinct from endometriosis rather than regarded as a subclassification. The diagnosis of adenomyosis should employ standard criteria that are accessible, replicable, noninvasive, and cost-effective. The Morphological Uterus Sonographic Assessment (MUSA) is a standard and validated system to diagnose adenomyosis. However, not all markers in the MUSA correlate with clinically relevant outcomes. Analysis of outcomes according to each individual sonographic marker may be the key to correctly identifying significant phenotypes of adenomyosis and evaluating its true impact on reproduction.

My notes (saved in your browser only)

Outcome instruments

MUSA COS-Endo-2020

Condition tags

endometriosisadenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (12)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK